← Back to Search

Herbal Supplement

Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 Diabetes

Phase 2
Waitlist Available
Led By Leanne De Souza, M.Sc.
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years

Summary

The study is a 2 phase double blind randomized placebo control trial. The objective is to asses the metabolic and therapeutic effects of American Ginseng (Panax quinquefolius L.) extract and Korean Red Ginseng (steamed Panax C.A. Meyer) extract in the management of type 2 diabetes in a 12 week period. One Hundred and twenty subjects with type 2 diabetes (hyperglycemia key inclusion criteria: HbAlc≥6.5% - ≤ 8.1% ) will participate in the study (36 men and 36 post-menopausal women).

Eligible Conditions
  • Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: 2Experimental Treatment1 Intervention
American Ginseng Capsules
Group II: 1Experimental Treatment1 Intervention
American Ginseng and American Red Ginseng Capsules
Group III: 3Placebo Group1 Intervention
Placebo Capsules

Find a Location

Who is running the clinical trial?

Unity Health TorontoLead Sponsor
559 Previous Clinical Trials
455,326 Total Patients Enrolled
14 Trials studying Diabetes
4,130 Patients Enrolled for Diabetes
Canadian Diabetes AssociationOTHER
42 Previous Clinical Trials
11,170 Total Patients Enrolled
5 Trials studying Diabetes
36 Patients Enrolled for Diabetes
Leanne De Souza, M.Sc.Principal InvestigatorClinical Nutrition and Risk Factor Modificatrion Centre
Vladimir Vuksan, PhDPrincipal InvestigatorClinical Nutritian and Risk Factor Modification Centre
20 Previous Clinical Trials
5,956 Total Patients Enrolled
2 Trials studying Diabetes
805 Patients Enrolled for Diabetes
Alexandra Jenkins, PhDPrincipal InvestigatorClinical Nutrition and Risk Factor Modificatrion Centre
2 Previous Clinical Trials
57 Total Patients Enrolled
Lawerence Leiter, MDPrincipal InvestigatorSt. Michaels Hospital
~7 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top